| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2024 ( Subtotal = $0 ) |
| | 2024 | 2021 | AMBERGEN, INC | 44 MANNING RD | BILLERICA | MA | 01821-3947 | MIDDLESEX | USA | R44AG067866 | Photocleavage Technology for Blood-based Multi-Biomarker Alzheimer's Disease Assay | 000 | 2 | NIH | 9/6/2024 | $0 |
|
| Issue Date FY: 2023 ( Subtotal = $2,970,103 ) |
| | 2023 | 2023 | AMBERGEN, INC | 44 MANNING RD | BILLERICA | MA | 01821-3947 | MIDDLESEX | USA | R44AG078097 | Photocleavable Mass-Tags for Spatial Multiomics of Alzheimer?s Brain Tissue | 000 | 2 | NIH | 8/2/2023 | $1,081,032 |
| | 2023 | 2023 | AMBERGEN, INC | 44 MANNING RD | BILLERICA | MA | 01821-3947 | MIDDLESEX | USA | R44AI165129 | New Technology for High-Resolution Antibody Profiling for SARS-CoV-2 | 000 | 2 | NIH | 7/26/2023 | $978,625 |
| | 2023 | 2023 | AMBERGEN, INC | 44 MANNING RD | BILLERICA | MA | 01821-3947 | MIDDLESEX | USA | R44MH132196 | A Highly Multiplexed, Multiomic 3D Mouse Brain Map Using MALDI-IHC | 000 | 2 | NIH | 7/24/2023 | $910,446 |
| | 2023 | 2021 | AMBERGEN, INC | 44 MANNING RD | BILLERICA | MA | 01821-3947 | MIDDLESEX | USA | R44AG067866 | Photocleavage Technology for Blood-based Multi-Biomarker Alzheimer's Disease Assay | 000 | 2 | NIH | 5/4/2023 | $0 |
|
| Issue Date FY: 2022 ( Subtotal = $3,417,685 ) |
| | 2022 | 2022 | AMBERGEN, INC | 313 PLEASANT ST STE 4 | WATERTOWN | MA | 02472-2491 | MIDDLESEX | USA | R44AI165129 | New Technology for High-Resolution Antibody Profiling for SARS-CoV-2 | 000 | 1 | NIH | 8/19/2022 | $978,625 |
| | 2022 | 2022 | AMBERGEN, INC | 313 PLEASANT ST STE 4 | WATERTOWN | MA | 02472-2491 | MIDDLESEX | USA | R44AG078097 | Photocleavable Mass-Tags for Spatial Multiomics of Alzheimer?s Brain Tissue | 000 | 1 | NIH | 8/15/2022 | $1,354,952 |
| | 2022 | 2022 | AMBERGEN, INC | 313 PLEASANT ST STE 4 | WATERTOWN | MA | 02472-2491 | MIDDLESEX | USA | R44MH132196 | A Highly Multiplexed, Multiomic 3D Mouse Brain Map Using MALDI-IHC | 000 | 1 | NIH | 9/15/2022 | $1,084,108 |
| | 2022 | 2020 | AMBERGEN, INC | 44 MANNING RD | BILLERICA | MA | 01821-3947 | MIDDLESEX | USA | R44CA236097 | Highly Multiplexed Nanoscale Mass Spectrometric Imaging of Cancer Tissues | 000 | 3 | NIH | 6/17/2022 | $0 |
|
| Issue Date FY: 2021 ( Subtotal = $1,249,958 ) |
| | 2021 | 2021 | AMBERGEN, INC | 313 PLEASANT ST STE 4 | WATERTOWN | MA | 02472-2491 | MIDDLESEX | USA | R44AG067866 | Photocleavage Technology for Blood-based Multi-Biomarker Alzheimer's Disease Assay | 000 | 2 | NIH | 6/16/2021 | $1,249,958 |
| | 2021 | 2019 | AMBERGEN, INC | 313 PLEASANT ST STE 4 | WATERTOWN | MA | 02472-2491 | MIDDLESEX | USA | R44AI100424 | Multiplexed Bead-based In Vitro Pediatric Allergy Test | 000 | 7 | NIH | 7/6/2021 | $0 |
|
| Issue Date FY: 2020 ( Subtotal = $2,249,702 ) |
| | 2020 | 2020 | AMBERGEN, INC | 313 PLEASANT ST STE 4 | WATERTOWN | MA | 02472-2491 | MIDDLESEX | USA | R44AG067866 | Photocleavage Technology for Blood-based Multi-Biomarker Alzheimer's Disease Assay | 000 | 1 | NIH | 7/31/2020 | $1,249,958 |
| | 2020 | 2020 | AMBERGEN, INC | 313 PLEASANT ST STE 4 | WATERTOWN | MA | 02472-2491 | MIDDLESEX | USA | R44CA236097 | Highly Multiplexed Nanoscale Mass Spectrometric Imaging of Cancer Tissues | 000 | 3 | NIH | 8/17/2020 | $999,744 |
| | 2020 | 2018 | AMBERGEN, INC | 313 PLEASANT ST STE 4 | WATERTOWN | MA | 02472-2491 | MIDDLESEX | USA | R43CA236097 | Highly Multiplexed Nanoscale Mass Spectrometric Imaging of Cancer Tissues | 000 | 1 | NIH | 4/25/2020 | $0 |
| | 2020 | 2018 | AMBERGEN, INC | 313 PLEASANT ST STE 4 | WATERTOWN | MA | 02472-2491 | MIDDLESEX | USA | R44GM105249 | Mass Spectrometric Bead-Imaging of Off-Target Drug Interactions | 000 | 5 | NIH | 2/8/2020 | $0 |
|
| Issue Date FY: 2019 ( Subtotal = $1,999,744 ) |
| | 2019 | 2019 | AMBERGEN, INC | 313 PLEASANT ST STE 4 | WATERTOWN | MA | 02472-2491 | MIDDLESEX | USA | R44AI100424 | Multiplexed Bead-based In Vitro Pediatric Allergy Test | 000 | 7 | NIH | 11/29/2018 | $1,000,000 |
| | 2019 | 2019 | AMBERGEN, INC | 313 PLEASANT ST STE 4 | WATERTOWN | MA | 02472-2491 | MIDDLESEX | USA | R44CA236097 | Highly Multiplexed Nanoscale Mass Spectrometric Imaging of Cancer Tissues | 000 | 2 | NIH | 9/17/2019 | $999,744 |
|
| Issue Date FY: 2018 ( Subtotal = $1,991,487 ) |
| | 2018 | 2018 | AMBERGEN, INC | 313 PLEASANT ST STE 4 | WATERTOWN | MA | 02472-2491 | MIDDLESEX | USA | R44GM105249 | Mass Spectrometric Bead-Imaging of Off-Target Drug Interactions | 000 | 5 | NIH | 6/19/2018 | $753,500 |
| | 2018 | 2018 | AMBERGEN, INC | 313 PLEASANT ST STE 4 | WATERTOWN | MA | 02472-2491 | MIDDLESEX | USA | R44AI100424 | Multiplexed Bead-based In Vitro Pediatric Allergy Test | 000 | 6 | NIH | 1/9/2018 | $937,987 |
| | 2018 | 2018 | AMBERGEN, INC | 313 PLEASANT ST STE 4 | WATERTOWN | MA | 02472-2491 | MIDDLESEX | USA | R43CA236097 | Highly Multiplexed Nanoscale Mass Spectrometric Imaging of Cancer Tissues | 000 | 1 | NIH | 8/31/2018 | $300,000 |
|
| Issue Date FY: 2017 ( Subtotal = $753,500 ) |
| | 2017 | 2017 | AMBERGEN, INC | 313 PLEASANT ST STE 4 | WATERTOWN | MA | 02472-2491 | MIDDLESEX | USA | R44GM105249 | Mass Spectrometric Bead-Imaging of Off-Target Drug Interactions | 000 | 4 | NIH | 6/27/2017 | $753,500 |
| | 2017 | 2016 | AMBERGEN, INC | 313 PLEASANT ST STE 4 | WATERTOWN | MA | 02472-2491 | MIDDLESEX | USA | R44AI100424 | Multiplexed Bead-based In Vitro Pediatric Allergy Test | 000 | 5 | NIH | 7/28/2017 | $0 |
| | 2017 | 2016 | AMBERGEN, INC | 313 PLEASANT ST STE 4 | WATERTOWN | MA | 02472-2491 | MIDDLESEX | USA | R43CA203647 | Photocleavage Technology for Improved Serum-based Multi-Biomarker Cancer Assays | 000 | 1 | NIH | 8/2/2017 | $0 |
| | 2017 | 2015 | AMBERGEN, INC | 313 PLEASANT ST STE 4 | WATERTOWN | MA | 02472-2491 | MIDDLESEX | USA | R44CA161965 | Global Proteomic Screening by MALDI Spectrometric Imaging of Protein-Bead Arrays | 000 | 4 | NIH | 8/8/2017 | $0 |
|
| Issue Date FY: 2016 ( Subtotal = $1,977,405 ) |
| | 2016 | 2016 | AMBERGEN | 1106 COMMONWEALTH AVENUE | BOSTON | MA | 02215-1100 | SUFFOLK | USA | R43CA203647 | Photocleavage Technology for Improved Serum-based Multi-Biomarker Cancer Assays | 000 | 1 | NIH | 7/26/2016 | $225,000 |
| | 2016 | 2016 | AMBERGEN | 1106 COMMONWEALTH AVENUE | BOSTON | MA | 02215-1100 | SUFFOLK | USA | R44AI100424 | Multiplexed Bead-based In Vitro Pediatric Allergy Test | 000 | 5 | NIH | 2/25/2016 | $998,905 |
| | 2016 | 2016 | AMBERGEN | 1106 COMMONWEALTH AVENUE | BOSTON | MA | 02215-1100 | SUFFOLK | USA | R44GM105249 | Mass Spectrometric Bead-Imaging of Off-Target Drug Interactions | 000 | 3 | NIH | 9/1/2016 | $753,500 |
|
| Issue Date FY: 2015 ( Subtotal = $1,498,649 ) |
| | 2015 | 2015 | AMBERGEN | 1106 COMMONWEALTH AVENUE | BOSTON | MA | 02215-1100 | SUFFOLK | USA | R44AI100424 | Multiplexed Bead-based In Vitro Pediatric Allergy Test | 000 | 4 | NIH | 2/13/2015 | $998,905 |
| | 2015 | 2015 | AMBERGEN | 1106 COMMONWEALTH AVENUE | BOSTON | MA | 02215-1100 | SUFFOLK | USA | R44CA161965 | Global Proteomic Screening by MALDI Spectrometric Imaging of Protein-Bead Arrays | 000 | 4 | NIH | 7/24/2015 | $499,744 |
|
| Issue Date FY: 2014 ( Subtotal = $1,986,438 ) |
| | 2014 | 2014 | AMBERGEN | 1106 COMMONWEALTH AVENUE | BOSTON | MA | 02215-1100 | SUFFOLK | USA | R44CA137948 | Proteome Bead-Display for Discovery of Tumor Antigens | 000 | 4 | NIH | 5/13/2014 | $487,788 |
| | 2014 | 2014 | AMBERGEN | 1106 COMMONWEALTH AVENUE | BOSTON | MA | 02215-1100 | SUFFOLK | USA | R44CA161965 | Global Proteomic Screening by MALDI Spectrometric Imaging of Protein-Bead Arrays | 000 | 3 | NIH | 7/30/2014 | $499,745 |
| | 2014 | 2014 | AMBERGEN | 1106 COMMONWEALTH AVENUE | BOSTON | MA | 02215-1100 | SUFFOLK | USA | R44AI100424 | Multiplexed Bead-based In Vitro Pediatric Allergy Test | 000 | 3 | NIH | 2/12/2014 | $998,905 |
| | 2014 | 2013 | AMBERGEN | 1106 COMMONWEALTH AVENUE | BOSTON | MA | 02215 | SUFFOLK | USA | R43AI100424 | Multiplexed Bead-based In Vitro Pediatric Allergy Test | 000 | 2 | NIH | 2/11/2014 | $0 |
| | 2014 | 2012 | AMBERGEN | 1106 COMMONWEALTH AVENUE | BOSTON | MA | 02215 | SUFFOLK | USA | R43CA161965 | Global Proteomic Screening by MALDI Spectrometric Imaging of Protein-Bead Arrays | 000 | 2 | NIH | 1/15/2014 | $0 |
|
| Issue Date FY: 2013 ( Subtotal = $1,135,459 ) (Continued on the next page) |
| | 2013 | 2013 | AMBERGEN | 1106 COMMONWEALTH AVENUE | BOSTON | MA | 02215 | SUFFOLK | USA | R43AI100424 | Multiplexed Bead-based In Vitro Pediatric Allergy Test | 001 | 2 | NIH | 2/11/2014 | $0 |
| | 2013 | 2013 | AMBERGEN | 1106 COMMONWEALTH AVENUE | BOSTON | MA | 02215-1100 | SUFFOLK | USA | R43AI100424 | Multiplexed Bead-based In Vitro Pediatric Allergy Test | 000 | 2 | NIH | 2/5/2013 | $298,459 |
| | 2013 | 2013 | AMBERGEN | 1106 COMMONWEALTH AVENUE | BOSTON | MA | 02215-1100 | SUFFOLK | USA | R43GM105249 | PHOTOCLEAVABLE BEAD TECHNOLOGY FOR GLYCOMICS | 000 | 2 | NIH | 8/28/2013 | $349,212 |
| | 2013 | 2013 | AMBERGEN | 1106 COMMONWEALTH AVENUE | BOSTON | MA | 02215-1100 | SUFFOLK | USA | R44CA137948 | Proteome Bead-Display for Discovery of Tumor Antigens | 001 | 3 | NIH | 5/22/2013 | $268,285 |
|
